에서 이용할 수 있어요!
자세히 알아보기
Azora Therapeutics
AZR
AZR
소개: Azora Therapeutics Inc is a biopharmaceutical company focused on developing treatments for serious inflammatory diseases. Azora owns the royalty-free rights to its technology, which is based on the development of potential best-in-class oral agonists of the aryl hydrocarbon receptor. Azora's lead program is AT177, a proprietary colon-targeted aryl hydrocarbon receptor (AhR) agonist designed to enable localized activation with limited systemic exposure in development for ulcerative colitis.
직원 수: 6
뉴스
긍정적
중립
부정적
투자 심리
3개월
긍정적
0%
중립
100%
부정적
0%
가격 차트는 Lightweight Charts™ 라이브러리로 구현했어요